Osteoporosis News

  • U.S. Appeals Court Revives Fosamax Warning Claims Against Merck A federal appeals court on Wednesday revived hundreds of claims by plaintiffs who accused Merck & Co of failing to adequately warn about the risks of thigh bone fractures associated with its osteoporosis drug Fosamax (alendronate).
  • Growth Hormone May Be Novel Therapy for Very Rare Bone Disease Recombinant human growth hormone (rhGH) is a potential novel therapy for fibrogenesis imperfecta ossium (FIO), a very rare but disabling and ultimately fatal bone disease, a small study from India suggests.

Osteoporosis Perspective